Team:Imperial College London/Autoinduction
From 2009.igem.org
JamesField (Talk | contribs) (→Results) |
JamesField (Talk | contribs) (→Rationale) |
||
Line 34: | Line 34: | ||
Before embarking on the creation of an autoinduction switch we reviewed a number of possible alternatives. A genetically encoded timer was initially considered however these present a considerable number of problems: | Before embarking on the creation of an autoinduction switch we reviewed a number of possible alternatives. A genetically encoded timer was initially considered however these present a considerable number of problems: | ||
+ | |||
+ | |||
+ | <!--template:----------------------------------------------------------------------------> | ||
+ | {| style="color:#CCC; background-color:#325d97;" cellpadding="6" cellspacing="0" border="3" | ||
+ | ! Malnutrition (from [1]) | ||
+ | ! PKU (from [2]) | ||
+ | |- style="color:#333; background-color:#CCCCFF;" cellpadding="6" cellspacing="0" border="1" | ||
+ | <!----------------------------------------biobricks----------------------------------------> | ||
+ | | 854 million people worldwide are undernourished (12.6% of the world population) | ||
+ | | 1 per 10,000 - 15,000 newborns are diagnosed with phenylketonuria in the USA | ||
+ | |- style="color:#333; background-color:#CCCCFF;" cellpadding="6" cellspacing="0" border="1" | ||
+ | | 820 million are in developing countries | ||
+ | | Prevalance Rate: approx 1 in 10,000 or 0.01% or 27,200 people in USA. | ||
+ | |} | ||
+ | <!-- | ||
+ | *PKU (statistics from [1]): | ||
+ | ** 1 per 10,000 - 15,000 newborns are diagnosed with phenylketonuria in the USA | ||
+ | ** Prevalance Rate: approx 1 in 10,000 or 0.01% or 27,200 people in USA | ||
+ | *Diabetes Mellitus (statistics from [2]): | ||
+ | **17,000,000 U.S. adults have physician-diagnosed diabetes (about 7.5 million males and 9.5 million females). | ||
+ | **1,600,000 new cases of diagnosed diabetes are diagnosed every year. | ||
+ | --> | ||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
1) Existing genetic timers are unable to provide a long enough delay. | 1) Existing genetic timers are unable to provide a long enough delay. |
Revision as of 20:41, 19 October 2009
Please delete as completed.
Autoinduction feedback from todays session.
1) Mention the purpose of AI - No timer because...
2) Don't link to the temporal control page here.
3) Have a rationale section.
4) Add what teams can reuse from this module.
5) Have a conclusion of the page at the end - couple of lines.
Contents |
Module Integration - Autoinduction
Overview
The autoinduction process switches on Module 2 following the accumulation of a predetermined concentration of polypeptide. The term 'autoinduction' was chosen as the flipping of this switch is triggered by the chemical composition of the media in which our chassis is grown. Thus the 'on signal' orginates from inside the system: hence 'autoinduction'.
Rationale
Before embarking on the creation of an autoinduction switch we reviewed a number of possible alternatives. A genetically encoded timer was initially considered however these present a considerable number of problems:
Malnutrition (from [1]) | PKU (from [2]) |
---|---|
854 million people worldwide are undernourished (12.6% of the world population) | 1 per 10,000 - 15,000 newborns are diagnosed with phenylketonuria in the USA |
820 million are in developing countries | Prevalance Rate: approx 1 in 10,000 or 0.01% or 27,200 people in USA. |
1) Existing genetic timers are unable to provide a long enough delay.
2) They are liable to fall out of phase.
3) They require multiple genes.
In contrast, using autoinduction media means that the length of our delay can be tuned by altering the composition of our media. In addition, a greater proportion of our bacterial population will react in synchrony to the input signal and thus commence Module 2 at the same time. Lastly, our autoinduction switch only requires a single promoter!
Initiation
Module 2 is triggered by a rise in levels of cyclic Adenosine Mono Phosphate (cAMP). This is because cAMP facilitates the dimerisation of the transcription factor CRP which induces transcription downstream of the PcstA promoter. The rise in cAMP is correlated with a fall in levels of the primary carbon source (glucose). Thus, by controlling the initial amount of glucose present in the system, we achieve a timer function for the start of Module 2.
Results
We have modelled autoinduction by a number of models, and we hope that experimental results will confirm which model is most applicable to our system.The first of our diauxic growth models is a cybernetic model developed by Kompala et al [1]. This model shows that glucose (S1) is used up before the secondary carbon source (S2). During this phase, the population (X) is in exponential grow until glucose (S1) runs out. This is followed by a stationary growth phase, and finally the population enters a second exponential growth phase as they start uptaking the secondary carbon source (S2). Another model was developed by Keasling [2] that takes into account the dynamics of the lactose operon. //Include a nice diauxic growth curve from the lab
About the models and simulations!